Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
Submitted by
admin
on April 6, 2022 - 12:24pm
Source:
Motley Fool
News Tags:
Legend Biotech
CAR-T
Immunocore
TCR immunotherapy
Headline:
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
snippet:
Legend Biotech is looking to bring its newly approved CAR-T cell therapy into earlier treatment lines.
Immunocore brought the first-ever TCR immunotherapy to market earlier this year.
Both companies could expand into much larger addressable markets in the coming years.
Do Not Allow Advertisers to Use My Personal information